Fisher & Paykel Healthcare Corporation Limited (FSPKF)
OTCMKTS · Delayed Price · Currency is USD
20.95
0.00 (0.00%)
Oct 15, 2025, 8:00 PM EDT
FSPKF Market Cap
FSPKF has a market cap or net worth of $11.90 billion as of October 17, 2025. Its market cap has decreased by -7.86% in one year.
Market Cap
11.90B
Enterprise Value
11.83B
Revenue
1.15B
Ranking
n/a
PE Ratio
55.65
Stock Price
$20.95
Market Cap Chart
Since February 28, 1992, FSPKF's market cap has increased from 130.80M to 11.90B, an increase of 8,995.54%. That is a compound annual growth rate of 14.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 11.90B | -5.62% |
| Dec 31, 2024 | 12.61B | 44.45% |
| Dec 29, 2023 | 8.73B | 5.18% |
| Dec 30, 2022 | 8.30B | -35.87% |
| Dec 31, 2021 | 12.94B | -5.34% |
| Dec 31, 2020 | 13.67B | 58.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 749.94M |
| Elite Pharmaceuticals | 652.54M |
| Veradigm | 514.01M |
| Nika Pharmaceuticals | 495.49M |
| CytoDyn | 365.33M |
| Northwest Biotherapeutics | 360.44M |
| Silence Therapeutics | 301.35M |
| American Oncology Network | 291.58M |